Jaren Madden
Investor Relations Contact presso SCHRÖDINGER, INC.
Posizioni attive di Jaren Madden
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| SCHRÖDINGER, INC. | Investor Relations Contact | 01/11/2020 | - |
| Public Communications Contact | 01/11/2020 | - |
Storia della carriera di Jaren Madden
Precedenti posizioni note di Jaren Madden
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Shire Plc /Old/
 Shire Plc /Old/ Miscellaneous Commercial ServicesCommercial Services Shire is a global specialty pharmaceutical company marketing products to defined customer groups (specialist doctors). Sales and marketing is a core Shire competence. Shire combines investment in product development with careful attention to risk management. Shire currently focuses on three therapeutic areas - central nervous system disorders (CNS), gastrointestinal (GI) and renal diseases. Shire has particular expertise in ADHD as a result of its development and marketing of the leading brand in the US market, ADDERALL and the new once a day version, ADDERALL XR. The group has a sales and marketing infrastructure with a broad portfolio of products targeting the US, Canada, UK, Republic of Ireland, France, Germany, Italy and Spain. Shire covers other significant pharmaceutical markets indirectly through distributors. They have already appointed such distributors including, Australia, Denmark, Finland, Hong Kong, Israel, Malaysia, Norway, Philippines, Singapore, South Africa, South Korea and Thailand. It is founded in 1986 | Chief Tech/Sci/R&D Officer | 01/11/2017 | 01/07/2018 |
| INFINITY PHARMACEUTICALS, INC. | Investor Relations Contact | 01/01/2010 | 01/01/2017 |
| Public Communications Contact | 01/01/2010 | 01/01/2017 | |
| GAMIDA CELL LTD. | Investor Relations Contact | 01/07/2018 | - |
| Public Communications Contact | 01/07/2018 | - |
Formazione di Jaren Madden
| Boston University | Masters Business Admin |
| University of Connecticut | Graduate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 6 |
| Regno Unito | 2 |
Posizioni
| Investor Relations Contact | 3 |
| Public Communications Contact | 3 |
| Chief Tech/Sci/R&D Officer | 1 |
Settori
| Health Technology | 3 |
| Consumer Services | 3 |
| Commercial Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 3 |
|---|---|
| INFINITY PHARMACEUTICALS, INC. | Health Technology |
| SCHRÖDINGER, INC. | Technology Services |
| GAMIDA CELL LTD. | Health Technology |
| Aziende private | 1 |
|---|---|
Shire Plc /Old/
Shire Plc /Old/ Miscellaneous Commercial ServicesCommercial Services Shire is a global specialty pharmaceutical company marketing products to defined customer groups (specialist doctors). Sales and marketing is a core Shire competence. Shire combines investment in product development with careful attention to risk management. Shire currently focuses on three therapeutic areas - central nervous system disorders (CNS), gastrointestinal (GI) and renal diseases. Shire has particular expertise in ADHD as a result of its development and marketing of the leading brand in the US market, ADDERALL and the new once a day version, ADDERALL XR. The group has a sales and marketing infrastructure with a broad portfolio of products targeting the US, Canada, UK, Republic of Ireland, France, Germany, Italy and Spain. Shire covers other significant pharmaceutical markets indirectly through distributors. They have already appointed such distributors including, Australia, Denmark, Finland, Hong Kong, Israel, Malaysia, Norway, Philippines, Singapore, South Africa, South Korea and Thailand. It is founded in 1986 | Commercial Services |
- Borsa valori
- Insiders
- Jaren Madden
- Esperienza
